Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

NCT00038168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Estramustine
DRUG: Taxol

Sponsor

M.D. Anderson Cancer Center